Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
1,277,304
-
Shares change
-
+24,377
-
Total reported value, excl. options
-
$16,463,186
-
Value change
-
+$85,912
-
Number of buys
-
15
-
Number of sells
-
18
-
Price
-
$12.89
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q3 2023
As of 30 Sep 2023 Nuvectis Pharma, Inc. - COM (NVCT) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,277,304 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BALDWIN BROTHERS LLC/MA, STATE STREET CORP, NORTHERN TRUST CORP, MARSHALL WACE, LLP, FORBES J M & CO LLP, RENAISSANCE TECHNOLOGIES LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This table shows 38 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.